MRI Sequence and Imaging Protocol Development
Launched by NATIONAL HEART CENTRE SINGAPORE · Jan 31, 2017
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
In medical research, there is a continuous need to develop new imaging techniques such as cardiovascular magnetic resonance (CMR) imaging. This will allow us to visualize and study the function and structure of the heart in greater detail so as to improve the diagnosis and treatment of patients with various cardiac conditions. The aim of the study is to optimise new CMR sequences, allowing the development of imaging protocols in future research studies.
This study will hence recruit 800 subjects for each of the following sub-studies:
1. Sub-study 1: Normal CMR protocols for assessment of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has no known significant medical history
- • Is able to give informed consent
- Exclusion Criteria:
- • Has contraindications to CMR implantable devices, cerebral aneutysm clips and cochlear implants
- • Has claustrophobia
- • Females who are pregnant
- • Is unable to comply with study protocols
About National Heart Centre Singapore
The National Heart Centre Singapore (NHCS) is a leading institution dedicated to advancing cardiovascular care and research in Singapore and the Asia-Pacific region. As a premier clinical trial sponsor, NHCS is committed to improving heart health through innovative research and clinical excellence. The center specializes in a wide range of cardiovascular conditions, leveraging cutting-edge technology and a multidisciplinary approach to develop and evaluate new therapies. With a strong emphasis on patient-centered care, NHCS collaborates with various stakeholders to enhance clinical outcomes and contribute to the global body of cardiovascular knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials